Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium

View ORCID ProfileBrecht Ingelbeen, View ORCID ProfileLaurène Peckeu, View ORCID ProfileMarie Laga, Ilona Hendrix, Inge Neven, View ORCID ProfileMarianne A. B. van der Sande, View ORCID ProfileEsther van Kleef
doi: https://doi.org/10.1101/2020.12.23.20248795
Brecht Ingelbeen
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brecht Ingelbeen
  • For correspondence: bingelbeen@itg.be
Laurène Peckeu
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laurène Peckeu
Marie Laga
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie Laga
Ilona Hendrix
2Department of Infectious Disease Prevention and Control, Common Community Commission, Brussels-Capital Region, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge Neven
2Department of Infectious Disease Prevention and Control, Common Community Commission, Brussels-Capital Region, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marianne A. B. van der Sande
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
3Julius Center for Health Sciences and Primary Care, Utrecht University, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marianne A. B. van der Sande
Esther van Kleef
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Esther van Kleef
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Reducing contacts is a cornerstone of containing SARS-CoV-2. We evaluated the effect of physical distancing measures and of school reopening on contacts and consequently on SARS-CoV-2 transmission in Brussels, a hotspot during the second European wave.

Methods Using SARS-CoV-2 case reports and contact tracing data during August-November 2020, we estimated changes in the age-specific number of reported contacts. We associated these trends with changes in the instantaneous reproduction number Rt and in age-specific transmission-events during distinct intervention periods in the Brussels region. Furthermore, we analysed trends in age-specific case numbers, pre- and post-school opening.

Findings When schools reopened and physical distancing measures relaxed, the weekly mean number of reported contacts surged from 2.01 (95%CI 1.73-2.29) to 3.04 (95%CI 2.93-3.15), increasing across all ages. The fraction of cases aged 10-19 years started increasing before school reopening, with no further increase following school reopening (risk ratio 1.23, 95%CI 0.79-1.94). During the subsequent month, 8.9% (67/755) of infections identified were from teenagers to other ages, while 17.0% (131/755) from other ages to teenagers. Rt peaked mid-September at 1.48 (95%CI 1.35-1.63). Reintroduction of physical distancing measures reduced reported contacts to 1.85 (95%CI 1.78-1.91), resulting in Rt dropping below 1 within 3 weeks.

Interpretation The second pandemic wave in Brussels was the result of increased contacts across all ages following school reopening. Stringent physical distancing measures, including closure of bars and limiting close contacts while schools remain open, reduced social mixing, in turn controlling SARS-CoV-2 transmission.

Funding European Commission H2020. GGC Brussel.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No specific funding was provided for this study, but authors were supported by grants from the European Union's Horizon 2020 programme under Grant Agreement MOOD nr 874850 and from the Common Community Commission of Brussels-Capital Region.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Institutional Review Board of the Institute of Tropical Medicine and the Ethics committee of the Antwerp University Hospital.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data analysis scripts are accessible on a GitHub repository: https://github.com/ingelbeen/covid19bxl. Case report data was available from the website of Sciensano, the Belgian health institute

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 24, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium
Brecht Ingelbeen, Laurène Peckeu, Marie Laga, Ilona Hendrix, Inge Neven, Marianne A. B. van der Sande, Esther van Kleef
medRxiv 2020.12.23.20248795; doi: https://doi.org/10.1101/2020.12.23.20248795
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium
Brecht Ingelbeen, Laurène Peckeu, Marie Laga, Ilona Hendrix, Inge Neven, Marianne A. B. van der Sande, Esther van Kleef
medRxiv 2020.12.23.20248795; doi: https://doi.org/10.1101/2020.12.23.20248795

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (455)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5297)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (760)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (702)
  • Health Policy (363)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5938)
  • Intensive Care and Critical Care Medicine (368)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (146)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2035)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)